Related Experiment Video
Updated: Apr 9, 2026
08:44
Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes
Published on: July 30, 2020
5.6K
A simple and effective method to improve bioavailability of glimepiride by utilizing hydrotropy technique
Haiying Li1, Lilan Ma1, Xiaxia Li1
1College of Pharmacy & Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Hebei University, Baoding 071002, China.
Summary
This study enhanced glimepiride (GLMP) solubility and bioavailability using meglumine (MU) via hydrotropy. The resulting glimepiride-meglumine (GLMP-MU) complex showed improved drug release and absorption in rats.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
Background:
- Glimepiride (GLMP) is a widely used antidiabetic medication.
- Poor solubility and bioavailability limit the efficacy of many drugs, including glimepiride.
- Hydrotropy offers a promising technique to enhance drug solubility.
Purpose of the Study:
- To improve the solubility and bioavailability of glimepiride (GLMP).
- To investigate the potential of meglumine (MU) as a hydrotrope for glimepiride complexation.
- To develop an effective glimepiride-meglumine (GLMP-MU) complex using lyophilization.
Main Methods:
- Complexation of glimepiride with meglumine.
- Lyophilization to obtain the glimepiride-meglumine (GLMP-MU) complex powder.
- Characterization using Fourier transform infrared spectroscopy (FT IR), X-ray powder diffraction (XRD), and differential scanning calorimetry (DSC).
- In vitro drug release studies and in vivo pharmacokinetic evaluation in rats.
Main Results:
- Fourier transform infrared spectroscopy confirmed hydrogen bond formation between glimepiride and meglumine.
- X-ray powder diffraction indicated an amorphous state of glimepiride in the GLMP-MU complex.
- Differential scanning calorimetry confirmed successful GLMP-MU complex preparation.
- The GLMP-MU complex exhibited significantly faster in vitro drug release compared to glimepiride alone.
- In vivo studies showed a significantly higher area under the curve (AUC) for GLMP-MU in rats.
Conclusions:
- Hydrotropy using meglumine is a simple and effective method to enhance glimepiride solubility and bioavailability.
- The developed GLMP-MU complex demonstrates improved dissolution and pharmacokinetic profiles.
- This approach holds potential for improving the therapeutic efficacy of glimepiride.
More Related Videos
Related Concept Videos
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
311
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
311
01:16Bioavailability Enhancement: Drug Solubility Enhancement
448
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
448
01:27Bioavailability Enhancement: Drug Permeability Enhancement
308
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
308
01:06Oral Hypoglycemic Agents: Glinides
977
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
977
01:30Modified-Release Drug Delivery Systems: Bioavailability
119
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
119
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
329
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
329